LENZ THERAPEUTICS INC (LENZ:NASDAQ)
$6.78 0.28 (4.3077%)
Analysed LENZ THERAPEUTICS INC (LENZ:NASDAQ) News Sources
LENZ Therapeutics Q1 Earnings Call Highlights
12-05-2026
marketbeat.com
LENZ Therapeutics Inc (LENZ) Q1 2026 Earnings Call Highlights: Strong Prescription Growth Amid ...
12-05-2026
yahoo.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe’s, Matador Resources, Toast and More
12-05-2026
247wallst.com
Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls
12-05-2026
yahoo.com
Top Midday Decliners
12-05-2026
yahoo.com
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Just Reported And Analysts Have Been Cutting Their Estimates
14-05-2026
yahoo.com
Things Look Grim For LENZ Therapeutics, Inc. (NASDAQ:LENZ) After Today's Downgrade
16-05-2026
yahoo.com
LENZ Therapeutics to Participate in Upcoming Investor Conferences
26-05-2026
yahoo.com
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
07-06-2026
yahoo.com
LENZ Therapeutics adds China partner for presbyopia drug VIZZ
08-06-2026
proactiveinvestors.com
What is the current price of LENZ THERAPEUTICS INC (LENZ:NASDAQ)?
The current price of LENZ THERAPEUTICS INC (LENZ:NASDAQ) is $6.78.
LENZ THERAPEUTICS INC (LENZ:NASDAQ) absolute price change since previous trading day?
The absolute price change of LENZ THERAPEUTICS INC (LENZ:NASDAQ) since the previous trading day is $0.28.
LENZ THERAPEUTICS INC (LENZ:NASDAQ) percentage price change since previous trading day?
The percentage price change of LENZ THERAPEUTICS INC (LENZ:NASDAQ) since the previous trading day is 4.3077%.
What is the most recent average sentiment score for LENZ THERAPEUTICS INC (LENZ:NASDAQ)?
The most recent average sentiment score for LENZ THERAPEUTICS INC (LENZ:NASDAQ) is 50 out of 100.
What is the most recent average sentiment for LENZ THERAPEUTICS INC (LENZ:NASDAQ)?
The most recent sentiment for LENZ THERAPEUTICS INC (LENZ:NASDAQ) is .
SEC-8K** Filing Available For LENZ THERAPEUTICS INC (LENZ:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.